Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

4932432K03Rik Activators

4932432K03Rik Activators encompass a range of chemical compounds that facilitate the enhancement of 4932432K03Rik through several signaling mechanisms. Forskolin and IBMX function by elevating intracellular cAMP levels, with Forskolin directly stimulating adenylyl cyclase and IBMX inhibiting phosphodiesterases. This accumulation of cAMP activates PKA, which subsequently phosphorylates various targets, potentially including 4932432K03Rik or its regulatory proteins, leading to enhanced activity. Similarly, PMA, by activating PKC, and ionophores like Ionomycin and A23187, by raising intracellular calcium levels, can trigger downstream protein kinases that phosphorylate and activate 4932432K03Rik. AMPK Activators are a diverse group of compounds that enhance the functional activity of AMPK through various biochemical mechanisms. AICAR and Metformin activate AMPK by increasing the intracellular AMP/ATP ratio, which allosterically activates the kinase and enhances its phosphorylation of downstream targets.

Resveratrol and Salicylate indirectly activate AMPK by modulating the activity of SIRT1 or inhibiting deacetylases, respectively, which results in the activation of LKB1 and subsequent phosphorylation of AMPK. Berberine and Phenformin also activate AMPK by altering the AMP/ATP ratio, while A-769662 directly binds to and activates the β1 subunit of AMPK. Dorsomorphin promotes AMPK activity through a negative feedback loop by inhibiting AMPK upstream kinase activity. The effects of Aspirin, through its metabolite salicylate, and Canagliflozin are rooted in their ability to induce an energy deficit, either through the promotion of LKB1-mediated phosphorylation or the excretion of glucose, respectively, leading to enhanced AMPK activity. Quercetin, through its antioxidant properties, and Alpha-lipoic acid, by modulating cellular energy status, indirectly lead to the activation of kinases that phosphorylate AMPK. Collectively, these activators work through unique yet converging pathways that culminate in the enhanced activity of AMPK, a central regulator of cellular energy homeostasis.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

Isobutylmethylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, thus preventing cAMP degradation. This results in an indirect activation of PKA, which subsequently can enhance the activity of 4932432K03Rik by phosphorylation of regulatory proteins.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

Phorbol 12-myristate 13-acetate (PMA) is a potent activator of protein kinase C (PKC). PKC activation influences signaling pathways that may result in increased phosphorylation and activation of 4932432K03Rik.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$78.00
$270.00
80
(4)

Ionomycin is a calcium ionophore, raising intracellular calcium levels which can activate calcium-dependent protein kinases. These kinases may enhance 4932432K03Rik function by modulating its state of phosphorylation.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187 is another calcium ionophore which increases intracellular calcium and activates calcium/calmodulin-dependent protein kinase (CaMK), potentially increasing 4932432K03Rik activation through phosphorylation-dependent mechanisms.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002 is a PI3K inhibitor. By inhibiting PI3K, it can lead to the activation of compensatory pathways that enhance the activity of 4932432K03Rik, such as those mediated by stress-activated protein kinases.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

PD98059 is a MEK inhibitor that can lead to the activation of alternative pathways that may upregulate the activity of 4932432K03Rik, as the cell seeks to compensate for the inhibited MEK pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

SB203580 is a p38 MAPK inhibitor, its inhibition may activate alternative signaling mechanisms that upregulate 4932432K03Rik activity.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor, which can lead to the activation of compensatory signaling pathways that indirectly enhance the activity of 4932432K03Rik.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Zaprinast, also a PDE5 inhibitor, leads to increased cGMP levels which may enhance 4932432K03Rik function through cGMP-dependent pathways, similar to Sildenafil.